Machine Learning

A new drug not only reduces osteoarthritis pain significantly but may also be the first to modify the disease itself, a landmark study in The Lancet reveals.

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

With $8M in funding, Huskeys' new AI platform sits on top of existing firewalls, promising to stop blocking customers and start generating revenue.

LIB Therapeutics' new monthly, room-temperature stable cholesterol drug shows strong long-term data, challenging rivals with a focus on patient ease-of-use.

Japanese pharma giant Meiji Seika Pharma backs Centivax's quest for a universal flu vaccine, a move that could revolutionize global pandemic preparedness.

Xplor Technologies and Clubessential merge, forming a $900M global leader with a new CEO and a bold eight-figure investment in artificial intelligence.

Australian medtech firm 4DMedical lands CE Mark for its revolutionary CT:VQ lung imaging, fueling a major European expansion with a fresh AU$83M investment.

A $15M grant fuels a revolutionary therapy for a fatal childhood disease, turning patients' own cells into 'living biofactories' to fight MPS I.

After promising results in a key patient subgroup, the PREVAiLS study will test if pridopidine can slow the relentless progression of ALS.

Following rapid growth and a private equity acquisition, DAS Health appoints Lee Horner to navigate healthcare's complex digital and cybersecurity challenges.

Neumora reveals promising data for Alzheimer's and schizophrenia drugs, but a delay in its obesity program highlights the high-stakes world of biotech.

Magnachip's new power semiconductors promise major efficiency and density gains for servers, tackling the soaring energy needs of the growing AI boom.

An Australian startup's new AI trading platform promises to master crypto volatility, but it enters a crowded market facing security and regulatory hurdles.

China's literary giant Yuewen leverages AI and a new generation of creators to build a global IP empire, from novels to AI-dramas and merchandise.

FoodTrack is ditching calorie counting, blending AI with Traditional Chinese wellness to offer personalized health insights from photos of your meals, face, and tongue.

Equasens reports a 9.1% revenue jump, driven by AI investment and key acquisitions, as the company navigates a major leadership change and market shifts.

Transform 2026 saw the launch of a national AI literacy plan and a new model for leadership, proving the future of work is about people, not just code.

Chery's iCAUR will unveil its 'new energy system' at Auto China 2026. The summit showcases a holistic vision beyond powertrains with new V23 and V27 SUVs.

A Denver clinic now offers Therapeutic Plasma Exchange for anti-aging. But does the science back up the high-cost promise of turning back the clock?